Hiroyuki Kobayashi

Hiroyuki Kobayashi has extensive work experience in various positions. From 2001 to 2010, they worked as a Psychiatrist at Keio University Hospital. In 2010, they became a Visiting Fellow at the University of Cambridge. From 2011 to 2015, they held multiple roles at Ohtake Pharmaceutical, including Head of Medical Affairs and Director of the Therapeutic Application Development Department. Hiroyuki then joined Eisai Pharmaceuticals in 2016, where they served as Chief Medical Officer Japan/Asia, Deputy President of the Neurology Business Group, and Corporate Officer until 2020. In 2018, they also worked as a Guest Lecturer at Tohoku University School of Medicine. Since 2020, Kobayashi has been the Founder & COO of a company called RINAX, as well as the Vice President of Healthcare and Wellness at Preferred Networks, Inc.

Hiroyuki Kobayashi attended Keio University, School of Medicine from 1995 to 2001. During this time, they earned a Doctor of Medicine (MD) degree as well as a Doctor of Philosophy (PhD) degree. No specific field of study is mentioned.